Mersana Therapeutics buy Truist Financial Co.
Start price
16.05.25
/
50%
€0.30
Target price
16.05.26
€8.93
Performance (%)
-13.68%
Price
25.07.25
€0.26
Summary
This prediction is currently active. The prediction for Mersana Therapeutics disappoints with a performance of -13.68%. This prediction currently runs until 16.05.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 0.998% | 0.948% |
| iShares Nasdaq 100 | 1.965% | 4.491% |
| iShares Nikkei 225® | 4.258% | 8.018% |
| iShares S&P 500 | 2.037% | 3.420% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target raised by analysts at Truist Financial Co. from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€5.00
29.02.24
29.02.24
€8.30
28.02.25
28.02.25
-90.28%
01.03.25
01.03.25
